N/A
Manufactured by Hospira, Inc.
21,707 FDA adverse event reports analyzed
Last updated: 2026-04-14
PHYTONADIONE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Hospira, Inc.. The most commonly reported adverse reactions for PHYTONADIONE include OFF LABEL USE, NAUSEA, VOMITING, FATIGUE, DYSPNOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PHYTONADIONE.
Out of 8,077 classified reports for PHYTONADIONE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 21,707 FDA FAERS reports that mention PHYTONADIONE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include OFF LABEL USE, NAUSEA, VOMITING, FATIGUE, DYSPNOEA, DRUG INEFFECTIVE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Hospira, Inc. in connection with PHYTONADIONE. Always verify the specific product and NDC with your pharmacist.